← Leaderboards
Ping-Ching Hsu
Univ Of Arkansas For Med Scis
$2,111,024
Attributed
$2,111,024
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $669.7K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,111,024 · 4
By mechanism
P20$951,665 · 1
R15$489,650 · 1
U24$394,309 · 1
P30$275,400 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Charles A O'Brien$15,608,722
- Yuet-Kin Leung$2,923,801
- Qiang Fu$659,075
- Carolyn Joanne Greene$459,069
- Larry J. Suva$4,307,107
Others in their field
Other Emerging Leaders on “Collaborations”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,010,808
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$242,102,241
- Lynn Briscoe · Leidos Biomedical Research, Inc.$109,176,575
- Klaus Romero · Critical Path Institute$86,053,372
Research focus
CollaborationsSamplingMalignant NeoplasmsCohortCancer TherapyPlasmaImmune ResponseMass Spectrum AnalysisTissuesBiologicalBiological MarkersMentorsMalignant Breast NeoplasmHigh Pressure Liquid ChromatographyCenters Of Research ExcellenceBloodBaseFollow-UpDrug DevelopmentRaceClinical ResearchCoupledCitric Acid CycleChemotherapy
Grant awards (7)
Promoting scientific and workforce diversity by enriching the Arkansas Rural Community Health Study (ARCH) among Mother-Daughter Pairs$394,309
U24 · FY2025 · ES · contact PI
Bioanalytical Core (Core B)$275,400
P30 · FY2025 · GM · contact PI
Metabolic Phenotypes of Doxorubicin-induced Cardiotoxicity in Breast Cancer$136,800
P20 · FY2023 · GM · contact PI
Metabolic Phenotypes of Doxorubicin-induced Cardiotoxicity in Breast Cancer$267,665
P20 · FY2022 · GM · contact PI
Metabolic Phenotypes of Doxorubicin-induced Cardiotoxicity in Breast Cancer$273,600
P20 · FY2021 · GM · contact PI
Metabolic Phenotypes of Doxorubicin-induced Cardiotoxicity in Breast Cancer$273,600
P20 · FY2020 · GM · contact PI
Genetic variability in DHFR and folic acid supplementation as novel risk factors for aggressive prostate cancer$489,650
R15 · FY2018 · CA · contact PI